01 DICLOFENAC SODIUM (1)
01 FOUGERA PHARMS (1)
01 GEL;TOPICAL (1)
01 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (1)
19
Fougera Pharmaceuticals Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DICLOFENAC SODIUM, with a corresponding application number 21005 and regulatory information .
proudly manufactured in the
approval since 2000-10-16
Fougera Pharmaceuticals Inc.'s SOLARAZE GEL;TOPICAL, medication with 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of DICLOFENAC SODIUM.